Home | Survey | Payment| Talks & Presentations | Job Opportunities
Journals   A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Science China Life Sciences
1006-9305
2015 Issue 12
Fighting against hematological malignancy in China: from unique system to global impact
LV Meng;HUANG XiaoJun;Peking University People’s Hospital;Peking University Institute of Hematology;Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation;Peking-Tsinghua Center for Life Sciences;
..............page:1183-1190
Natural products against hematological malignancies and identification of their targets
XU Ying;LIU JinBao;WU YingLi;GUO QingLong;SUN HanDong;CHEN GuoQiang;Department of Pathophysiology;Chemical Biology Division of Shanghai Universities E-Institutes;Key Laboratory of Cell Differentiation and Apoptosis of Ministry of Education;Shanghai Jiao Tong University School of Medicine;Institute of Health Sciences;Shanghai Institutes for Biological Sciences of Chinese Academy of Sciences-Shanghai Jiao Tong University School of Medicine;State Key Laboratory of Respiratory Disease;Protein Modification and Degradation Lab;Department of Pathophysiology;Guangzhou Medical University;State Key Laboratory of Natural Medicines;Jiangsu Key Laboratory of Carcinogenesis and Intervention;China Pharmaceutical University;State Key Laboratory of Phytochemistry and Plant Resources in West China;Kunming Institute of Botany;Chinese Academy of Sciences;
..............page:1191-1201
An overview of chronic myeloid leukemia and its animal models
MA WeiXu;MA Ning;CHEN XiaoHui;ZHANG YiYue;ZHANG WenQing;Key Laboratory of Zebrafish Modeling and Drug Screening for Human Diseases of Guangdong Higher Education Institutes;Department of Developmental Biology;Institute of Genetic Engineering;School of Basic Medical Sciences;Southern Medical University;
..............page:1202-1208
Regulation of hematopoietic stem cells in the niche
ZHAO Meng;LI LinHeng;Stowers Institute for Medical Research;Department of Pathology & Laboratory Medicine;University of Kansas Medical Center;
..............page:1209-1215
Inhibitory leukocyte immunoglobulin-like receptors in cancer development
ZHANG FeiFei;ZHENG JunKe;KANG XunLei;DENG Mi;LU ZhiGang;KIM Jaehyup;ZHANG ChengCheng;Hongqiao International Institute of Medicine;Shanghai Tongren Hospital;Faculty of Basic Medicine;Shanghai Jiao Tong University School of Medicine;Key Laboratory of Cell Differentiation and Apoptosis of Chinese Ministry of Education;Shanghai Jiao Tong University School of Medicine;Departments of Physiology and Developmental Biology;University of Texas Southwestern Medical Center;
..............page:1216-1225
Mechanisms of action of BCL6 during germinal center B cell development
HUANG ChuanXin;MELNICK Ari;Shanghai Institute of Immunology & Department of Immunobiology and Microbiology;Shanghai Jiao Tong University School of Medicine;Division of Hematology and Medical Oncology;Department of Medicine;Weill Cornell Medical College;
..............page:1226-1232
NK cell-based cancer immunotherapy: from basic biology to clinical application
LI Yang;YIN Jie;LI Ting;HUANG Shan;YAN Han;LEAVENWORTH Jian Mei;WANG Xi;Department of Cell Biology;2011 Collaborative Innovation Center of Tianjin for Medical Epigenetics;Laboratory of Epigenetics in Development and Tumorigenesis;Tianjin Research Center of Basic Medical Sciences;Tianjin Key Laboratory of Medical Epigenetics;Tianjin Medical University;Department of Cancer Immunology and Virology;Dana-Farber Cancer Institute;Department of Microbiology and Immunobiology;Division of Immunology;Harvard Medical School;
..............page:1233-1245
Molecular pathogenesis of lymphomas of mucosa-associated lymphoid tissue—from(auto)antigen driven selection to the activation of NF-?B signaling
ZHANG YiAn;WEI Zheng;LI Jing;LIU Peng;Department of Hematology;Zhongshan Hospital;Fudan University;
..............page:1246-1255
On signaling pathways: hematopoietic stem cell specification from hemogenic endothelium
LONG Yan;HUANG He;Bone Marrow Transplantation Center;The First Affiliated Hospital;School of Medicine;Zhejiang University;
..............page:1256-1261
The role of circulating miRNAs in multiple myeloma
ZHANG Ji;XIAO XiaoJuan;LIU Jing;Department of Hematology;The First Affiliated Hospital;University of South China;State Key Laboratory of Medical Genetics & School of Life Sciences;Central South University;
..............page:1262-1269
Novel methods for studying normal and disordered erythropoiesis
LIU Jing;HAN Xu;AN XiuLi;State Key Laboratory of Medical Genetics & School of Life Sciences;Central South University;College of Life Sciences;Zhengzhou University;
..............page:1270-1275
Characteristics of the TCR Vβ repertoire in imatinib-resistant chronic myeloid leukemia patients with ABL mutations
XU Ling;LU Yu Hong;LAI Jing;YU Wei;ZHANG Yi Kai;JIN Zhen Yi;XU Yan;CHEN Jie;ZHA Xian Feng;CHEN Shao Hua;YANG Li Jian;LI Yang Qiu;Institute of Hematology;Jinan University;Department of Hematology;First Affiliated Hospital;Jinan University;Department of Hematology;Guangzhou No.12 People’s Hospital;Key Laboratory for Regenerative Medicine of Ministry of Education;Jinan University;Department of clinical laboratory;First Affiliated Hospital;Jinan University;
..............page:1276-1281
Pathways related to PMA-differentiated THP1 human monocytic leukemia cells revealed by RNA-Seq
ZENG ChengWu;WANG WenTao;YU XiBao;YANG LiJian;CHEN ShaoHua;LI YangQiu;First Affiliated Hospital;Jinan University;Institute of Hematology;Medical College;Jinan University;Key Laboratory for Regenerative Medicine of Ministry of Education;Jinan University;Key Laboratory of Gene Engineering of the Ministry of Education;State Key Laboratory for Biocontrol;School of Life Science;Sun Yat-sen University;
..............page:1282-1287
NK cells play a significant role in immunosurveillance at the early stage of MLL-AF9 acute myeloid leukemia via CD226/CD155 interactions
WANG YaJie;CHEN Chen;DONG Fang;MA ShiHui;XU Jing;GONG YueMin;CHENG Hui;ZHOU Yuan;CHENG Tao;HAO Sha;State Key Laboratory of Experimental Hematology;Institute of Hematology& Blood Diseases Hospital;Collaborative Innovation Center for Cancer Medicine;Center for Stem Cell Medicine;Chinese Academy of Medical Sciences & Peking Union Medical College;Department of Stem Cell and Regenerative Medicine;Chinese Academy of Medical Sciences & Peking Union Medical College;
..............page:1288-1298
Receptor-mediated inhibitory mechanisms and the regulation of platelet function
CHENG ZhiPeng;LIU JunLing;Department of Biochemistry and Molecular Cell Biology;Shanghai Jiao Tong University School of Medicine;Institute of Hematology;Union Hospital;Tongji Medical College;Huazhong University of Science and Technology;
..............page:1299-1301
The priming induction regimen of HAG as a low dose chemotherapy strategy in AML clonal evolution
CHEN AiLi;YANG JingYi;HU ShaoYan;WANG Qian-Fei;Key Laboratory of Genomic and Precision Medicine;Beijing Institute of Genomics;Chinese Academy of Sciences;The Children’s Hospital of Soochow University;
..............page:1302-1305
Erratum to: Unraveling the mechanisms of synapse formation and axon regeneration: the awesome power of C. elegans genetics
JIN YiShi;Howard Hughes Medical Institute;Section of Neurobiology;Division of Biological Sciences;University of California;
..............page:1306
SUBJECT INDEX TO VOLUME 58(2015)
..............page:1307-1316
Instructions for Authors
..............page:1317